The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 in the green ahead of Fed rate decision

Wed, 03rd May 2023 16:58

(Alliance News) - Stocks in London were higher at the close on Wednesday as investor waited with bated breath for the US Federal Reserve's next interest rate decision.

The FTSE 100 index closed up 15.34 points, or 0.2% at 7,788.37 on Wednesday. The FTSE 250 ended up 51.37 points, or 0.3%, at 19,365.60. The AIM All-Share closed up just 0.1 of a point at 828.28.

The Cboe UK 100 ended up 0.2% at 778.87, the Cboe UK 250 closed flat at 16,990.58, and the Cboe Small Companies ended up 0.2% at 13,632.18.

"The Fed is widely expected to deliver what could be its final rate hike in this cycle of 25 basis points so barring any big shock on that score, the focus will fall on the comments which accompany the decision," said Russ Mould, investment director at AJ Bell.

The US central bank will announce its decision at 1900 BST. A press conference with Fed Chair Jerome Powell will be held shortly after at 1930 BST.

Investors will be analysing Powell's speech for hints about where the Fed will be going in the future, and at what pace.

"A more dovish stance than initially expected should boost appetite towards riskier assets, while another hawkish wording could significantly dent investor sentiment to stocks and send benchmarks further down," said Pierre Veyret, technical analyst at ActivTrades.

According to the CME FedWatch tool, a quarter-point hike is overwhelming expected, with market seeing just an 15% chance of rates remaining the same.

At its last meeting in March, the Fed lifted US interest rates by 25 basis points in a unanimous decision, taking the federal funds rate range to 4.75% to 5.00%.

The dollar slipped in Europe amid the pre-Fed jitters.

Sterling was quoted at USD1.2543 at the London equities close on Wednesday, up from USD1.2463 at the close on Tuesday. The euro stood at USD1.1057, higher against USD1.0986.

Against the yen, the dollar was trading at JPY135.09, lower compared to JPY136.55 late Tuesday.

Meanwhile, stocks in New York were mixed at the London equities close, with the Dow Jones Industrial Average down 0.2%, the S&P 500 index flat, and the Nasdaq Composite up 0.3%.

In London, Pearson was the top blue-chip performer, up 10%, reserving some of yesterday's steep losses which saw the stock finish 15% lower.

The stock was knocked after shares in online learning service Chegg plunged in New York on Tuesday. Chegg admitted that artificial intelligence chatbot ChatGPT had affected how many students were signing up to its services, leading the company to withdraw its guidance for the full year.

Haleon dropped 2.8% after the Financial Times reported that Pfizer will begin offloading its 32% stake in the consumer healthcare products firm as it focuses on reducing debt linked to its USD43 billion acquisition of Seagen and boosting shareholder returns.

Pfizer Chief Financial Officer Dave Denton told the newspaper it will begin selling its interest within months, but in a "slow and methodical" manner" to prevent undermining Haleon's market valuation.

Haleon was spun-off after GSK and Pfizer combined their consumer healthcare operations in 2019 before opting to list the joint-venture on the London Stock Exchange, leaving GSK and Pfizer with a 13.5% and 32% stake, respectively.

GSK closed down 0.2% in London. Pfizer was 1.0% lower in New York.

Lloyds fell 3.4%, after it reported a sharp drop in customer deposits in the first quarter of 2023.

The Edinburgh-based bank said customer deposits fell by GBP2.2 billion to GBP473.1 billion. This was "including a reduction in Retail current account balances of GBP3.5 billion, partly driven by seasonal customer outflows, including tax payments, higher spend and a more competitive market," Lloyds said.

Nonetheless, Lloyds backed annual guidance of a banking net interest margin over 305 basis points, and return on tangible equity of around 13%. It added that its asset quality remained resilient, and said its portfolio is "well-positioned" in the context of cost of living pressures.

In the FTSE 250, TI Fluid Systems jumped 14% after the company backed its annual outlook, as it reported its first-quarter revenue rose 15% year-on-year to EUR869.8 million.

"The group's performance through Q1 2023 has been encouraging and our outlook for the year remains unchanged, with constant currency revenue growth outperformance compared to [light vehicle production] growth, adjusted [earnings before interest & tax] margins to expand above 6%," TI Fluid Systems said.

Elsewhere in London, Card Factory dropped 5.6% despite reporting a full-year profit rise as the greeting card retailer shook off inflationary pressure and a hit to its online channel from UK postal strikes.

The firm said revenue for the year ended January 31 rose 27% to GBP463.4 million, from GBP364.4 million, while its pretax profit more than tripled to GBP52.4 million from GBP11.1 million the year before.

Looking ahead, Card Factory said trading for the new financial year is "slightly ahead" of expectations, adding it is confident in its ability to withstand inflationary pressures moving forward.

On AIM, Mirriad Advertising shares surged to 4.53p from 1.01p at Tuesday's close.

The in-content advertising company said it has worked with Microsoft to build a new application programming interface, as part of a roadmap for "adopting Microsoft Azure and its AI capabilities for various use-cases".

Mirriad did not disclose any financial details of the collaboration.

In European equities on Wednesday, the CAC 40 in Paris ended up 0.3%, while the DAX 40 in Frankfurt ended 0.6% higher.

After the Fed announces its interest rate decision at 1900 BST, investor attention will shift to the European Central Bank which will reveal its own rate decision on Thursday.

The market is expecting the ECB to slow down its pace of interest rate hikes to a 25 basis point hike, but with sticky inflation and record low unemployment, there remains the possibility of another 50 basis point move.

The Frankfurt-based central bank will announce its decision at 1415 CEST on Thursday. A press conference with ECB President Christine Lagarde will follow at 1500 CEST.

At its last meeting in March, the ECB raised rates by 50 basis points, taking the interest rate on the main refinancing operations, the interest rate on the marginal lending facility, and the deposit facility to 3.50%, 3.75% and 3.00% respectively.

Brent oil was quoted at USD72.01 a barrel at the London equities close on Wednesday, down sharply from USD76.17 late Tuesday. Gold was quoted at USD2,025.44 an ounce, higher against USD2,011.85 at the close on Tuesday, boosted by weakness in the US dollar.

Chris Beauchamp, chief market analysts at IG, said: "Oil prices appear to be the one area really concerned about a recession and a slump in demand, and it seems OPEC will have to think about another cut in production fairly soon if a move below the March lows is to be avoided."

In Thursday's UK corporate calendar, there are first quarter results from oil major Shell as well as trading statements from Next and BAE Systems.

In the economic calendar, there are services PMI prints from the UK and the EU from 0900 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.